SPECIFIC PAIRS OF HEAVY / LIGHT CHAINS IN THE MONITORING OF PATIENTS WITH MULTIPLE MYELOMA

被引:0
|
作者
de Veas Silva, Garcia J. L. [1 ]
Lopez Velez, M. d. S. [1 ]
De Haro Romero, M. T. [1 ]
Espuch Oliver, A. [1 ]
Gonzalez Cejudo, T. [1 ]
Gonzalez Navarro, P. [1 ]
Perez Gutierrez, E. [1 ]
Palacios, R. [1 ]
Bermudo Guitarte, C. [2 ]
Rios Tamayo, R. [3 ]
Garcia Lario, J., V [1 ]
De Haro Munoz, T. [1 ]
机构
[1] Hosp Univ Campus Salud, Granada, Spain
[2] Hosp Univ Virgen Macarena, Seville, Spain
[3] Hosp Univ Virgen de las Nieves, Granada, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PC-036
引用
收藏
页码:121 / 121
页数:1
相关论文
共 50 条
  • [31] Heavy-light chain pairs as an alternative method to monitor isatuximab-based treatment responses in multiple myeloma patients
    Medina Gonzalez, L.
    Pico Picos, M. A.
    Laburu Danobeitia, E.
    Gonzalez De la Fuente, G.
    Suarez Diaz, R. M.
    Diaz Gomez, M.
    Diez Fuentes, M. L.
    CLINICA CHIMICA ACTA, 2024, 558
  • [32] Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
    de Veas Silva, Jose Luis Garcia
    Guitarte, Carmen Bermudo
    Valladares, Paloma Menendez
    Rojas Noboa, Johanna Carolina
    Kestler, Krysta
    Millan, Rafael Duro
    PLOS ONE, 2016, 11 (11):
  • [33] The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma
    Mancuso, Salvatrice
    Carlisi, Melania
    Serra, Nicola
    Sardo, Mariano
    Bertuglia, Giuseppe
    Pappalardo, Emanuela
    Siragusa, Sergio
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2020, 17 (01)
  • [34] Potential of serum free light chains for managing patients with multiple myeloma and amyloidosis
    Bradwell, AR
    Carr-Smith, HD
    Mead, GP
    Harvey, TC
    BONE MARROW TRANSPLANTATION, 2002, 29 : S98 - S99
  • [35] SYNTHESIS OF ABNORMAL HEAVY AND LIGHT-CHAINS IN MULTIPLE-MYELOMA WITH VISCERAL DEPOSITION OF MONOCLONAL IMMUNOGLOBULIN
    PREUDHOMME, JL
    MORELMAROGER, L
    BROUET, JC
    MIHAESCO, E
    MERY, JP
    SELIGMANN, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1980, 42 (03): : 545 - 553
  • [36] T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma
    Fagerberg, J
    Yi, Q
    Gigliotti, D
    Harmenberg, U
    Rudén, U
    Persson, B
    Österborg, A
    Mellstedt, H
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (05) : 671 - 680
  • [37] ASSESSMENT OF IGA HEAVY/LIGHT CHAIN IMMUNOASSAY UTILITY IN MULTIPLE MYELOMA PATIENTS
    Young, J.
    Stern, S.
    Behrens, J.
    Patel, P.
    Hennessy, L.
    Powner, D.
    Harding, S.
    Bansal, A.
    HAEMATOLOGICA, 2012, 97 : 604 - 604
  • [38] Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma
    Schreiner, Sarah
    Berghaus, Natalie
    Poos, Alexandra M.
    Raab, Marc S.
    Besemer, Britta
    Fenk, Roland
    Goldschmidt, Hartmut
    Mai, Elias K.
    Mueller-Tidow, Carsten
    Weinhold, Niels
    Hegenbart, Ute
    Huhn, Stefanie
    Schoenland, Stefan O.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 (02): : 86 - 94
  • [39] EVALUATION OF FREE LIGHT CHAINS (FLC) IN SERUM AND BONE MARROW IN PATIENTS WITH MULTIPLE MYELOMA
    Pizzuti, M.
    Chitarrelli, I.
    Smaldore, G.
    Girardi, A.
    Penitente, R.
    Pascale, S. P.
    Nuccorini, R.
    Coluzzi, S.
    Matturro, A.
    Attolico, I.
    Amendola, A.
    Cimminiello, M.
    Filardi, N.
    Vertone, D.
    HAEMATOLOGICA, 2016, 101 : S112 - S113
  • [40] Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using serum immunoassays specific for free immunoglobulin light chains.
    Bradwell, AR
    Mead, GP
    Carr-Smith, HD
    Drayson, MT
    BLOOD, 2001, 98 (11) : 157A - 157A